Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the effect of Withania somnifera on obsessive-compulsive disorder
IRCT2015070523079N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of withania somnifera in obsessive compulsive disorder (OCD), sponsored by Mashhad University of Medical Sciences. Started Feb 2015; status: completed.
02
Drugs
withania somnifera
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2015070523079N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015070523079N1.